<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Strict//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-strict.dtd"><html xml:lang="en" lang="en" xmlns="http://www.w3.org/1999/xhtml"><head><meta http-equiv="Content-Type" content="text/html; charset=utf-8" /><meta name="ROBOTS" content="NOARCHIVE" /><meta name="googlebot" content="nosnippet" /><meta name="Document-Type" content="monograph" /><meta name="keywords" content="Valaciclovir; Valtrex; Valaciclovir" /><meta name="IX" content="Valtrex; Valaciclovir" /><meta name="IXM" content="Valaciclovir" /><title>VALACICLOVIR: British National Formulary</title><link type="text/css" rel="stylesheet" href="../../theme/theme.css" /><link type="text/css" rel="stylesheet" href="../../theme/print.css" media="print" /><link type="text/css" rel="stylesheet" href="59/style.css" /><link type="image/x-icon" rel="shortcut icon" href="favicon.ico" /><link rel="stylesheet" type="text/css" href="style/screen.css" media="screen" /><link rel="stylesheet" type="text/css" href="style/print.css" media="print" /><link rel="contents" type="text/html" href="index.htm" /><link rel="help" type="text/html" href="http://www.medicinescomplete.com/mc/help_page.htm" /><link rel="start" type="text/html" href="index.htm" title="British National Formulary" /><link rel="copyright" type="text/html" href="PHP0-publication-information.htm" title="Copyright information" /><link rel="bookmark" title="Skip Navigation" href="PHP3853-valaciclovir.htm#pB" /><script type="text/javascript" src="https://ajax.googleapis.com/ajax/libs/jquery/1.7.0/jquery.min.js"></script><script type="text/javascript" src="../../scripts/jquery/jquery.tooltip.min.js"></script><script type="text/javascript" src="../../scripts/jquery/jquery.cookie.js"></script><script type="text/javascript" src="../../scripts/jquery/jquery.autosuggest.js"></script><script type="text/javascript" src="../../scripts/scripts.js"></script><style type="text/css">
  .contentsbox { position: fixed; z-index:1001;}
  .contentsbox_wrap {overflow:hidden;width:20px;height:130px; position:absolute;left:0;top:0;}
</style><!--[if lte IE 7]>
          <style type="text/css">
          .contentsbox {
          position: absolute;
          left: expression( ( 15 + ( ignoreMe2 = document.documentElement.scrollLeft ? document.documentElement.scrollLeft : document.body.scrollLeft ) ) + 'px' );
          top: expression( ( 250 + ( ignoreMe = document.documentElement.scrollTop ? document.documentElement.scrollTop : document.body.scrollTop) ) + 'px' );
          }
          .threecol_col3 {
          font-family: arial
          }
          .threecol_col3 a {
          font-family: verdana,helvetica,sans-serif
          }
          .threecol_col1 {
          font-family: arial
          }
          .threecol_col1 a {
          font-family: verdana,helvetica,sans-serif
          }
          div#pE {
          font-family: arial
          }
          div#pE a {
          font-family: verdana,helvetica,sans-serif
          }
          div#pK {
          font-family: arial
          }
          div#pK a {
          font-family: verdana,helvetica,sans-serif
          }
          </style>
          <![endif]--></head><body><?highlighter off?><div id="pU"><a id="pD" accesskey="s" rel="bookmark" href="PHP3853-valaciclovir.htm#pB" title="Skip Navigation">Skip Navigation</a><img src="../../images/mylogo.png" alt="BNF.org Free Access" id="pI" /><ul id="pZ"><li><a href="http://www.medicinescomplete.com/mc/account.htm">You are signed in as a member of <b>BNF.org Free Access</b></a></li><li> | <a href="http://www.medicinescomplete.com/mc/login.htm">Sign in different user</a></li><li> | <a href="http://www.medicinescomplete.com/mc/logout.htm">Sign out</a></li></ul><a href="http://www.medicinescomplete.com/mc/" title="Go to the MedicinesComplete home page"><img src="../../images/mc.png" alt="MedicinesComplete" /></a><ul id="pM"><li><a href="http://www.medicinescomplete.com/mc/" class="selected" accesskey="1" title="Home: access key 1"><strong><span>Home</span></strong></a></li><li><a href="http://www.medicinescomplete.com/mc/marketing/current/"><strong><span>Welcome</span></strong></a></li><li><a href="http://www.medicinescomplete.com/mc/feedback.htm?pub=bnf&amp;uri=PHP3853-valaciclovir.htm" accesskey="9" title="Feedback: access key 9"><strong><span>Feedback</span></strong></a></li><li><a href="http://www.medicinescomplete.com/mc/help.htm" accesskey="6" title="Help button: access key 6"><strong><span>Help</span></strong></a></li></ul></div><div id="pA"><div id="pY">British National Formulary</div><div id="pG">Printed from: Joint Formulary Committee.  <i>British National Formulary</i>. [online] London: BMJ Group and Pharmaceutical Press.. &lt; http://www.medicinescomplete.com/ &gt; [Accessed on 07 Oct 2012 (GMT)].</div><div id="pQ"><form id="searchForm" method="get" action="http://www.medicinescomplete.com/mc/bnf/current/search.htm"><fieldset><legend>Details</legend><label for="q">Search for</label><div id="qd"><div><input accesskey="4" type="text" id="q" name="q" /><input class="button" id="searchButton" type="submit" value="Search" name="searchButton" title="Search full text" /></div></div></fieldset></form><script type="text/javascript">$(document).ready(function(){$("#q").autoSuggest('http://www.medicinescomplete.com/mc/bnf/current/search/suggest.xml', {control: "#searchButton"});});</script></div></div><div id="pH"><div id="pN"><div id="pT"><span class="cA"><a href="http://www.medicinescomplete.com/mc/">Home</a></span> &gt; <a href="index.htm">BNF September 2012</a> &gt; <a href="PHP3253-infections.htm">5 Infections</a> &gt; <a href="PHP3742-antiviral-drugs.htm">5.3 Antiviral drugs</a> &gt; <a href="PHP3838-herpesvirus-infections.htm">5.3.2 Herpesvirus infections</a> &gt; <a href="PHP3839-herpes-simplex-and-varicellazoster-infection.htm">5.3.2.1 Herpes simplex and varicella–zoster infection</a></div><div id="pP"><div class="threecol_col1">◄ <a accesskey="[" href="PHP3851-inosine-pranobex.htm" title="Previous: INOSINE PRANOBEX">Previous page</a></div><div class="threecol_col2"> </div><div class="threecol_col3"><a accesskey="]" href="PHP3854-valaciclovir-non-proprietary.htm#PHP3854-valaciclovir-non-proprietary" title="Next: Valaciclovir">Next page</a> ►</div></div></div></div><div id="p1"><div id="sideBar"><h2>See Also</h2><ul><li><h3>AHFS Drug Information</h3></li><li><a href="http://www.medicinescomplete.com/mc/ahfs/2010/a395010.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Valacyclovir Hydrochloride</a><div class="breadcrumb"><p><strong>AHFS Drug Information</strong> &gt; Anti-infective Agents 8:00 &gt; Antivirals 8:18 &gt; Nucleosides and Nucleotides 8:18.32</p></div></li></ul><ul><li><h3>Stockley's Interaction Alerts</h3></li><li><a href="http://www.medicinescomplete.com/mc/alerts/2010/17168-a.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Interactions of Valaciclovir</a><div class="breadcrumb"><p><strong>Stockley's Interaction Alerts</strong> &gt; Interactants: V &gt; Interactions of Valaciclovir</p></div></li></ul><ul><li><h3>British National Formulary (4)</h3></li><li><a href="PHP3839-herpes-simplex-and-varicellazoster-infection.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">5.3.2.1 Herpes simplex and varicella–zoster infection</a><div class="breadcrumb"><p><strong>British National Formulary</strong> &gt; 5 Infections &gt; 5.3 Antiviral drugs &gt; 5.3.2 Herpesvirus infections</p></div></li><li><a href="PHP3854-valaciclovir-non-proprietary.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Valaciclovir</a><div class="breadcrumb"><p><strong>British National Formulary</strong> &gt; 5 Infections &gt; 5.3 Antiviral drugs &gt; 5.3.2 Herpesvirus infections &gt; 5.3.2.1 Herpes simplex and varicella–zoster infection &gt; VALACICLOVIR</p></div></li><li><a href="PHP3855-valtrex.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Valtrex®</a><div class="breadcrumb"><p><strong>British National Formulary</strong> &gt; 5 Infections &gt; 5.3 Antiviral drugs &gt; 5.3.2 Herpesvirus infections &gt; 5.3.2.1 Herpes simplex and varicella–zoster infection &gt; VALACICLOVIR</p></div></li><li><a class="seeAll" href="http://www.medicinescomplete.com/mc/related.htm?q=%22valaciclovir%22%22valaciclovir%22" onclick="pageTracker._trackEvent('Related-Topic','Related-See-All');">see all (4)</a></li></ul><ul><li><h3>BNF for Children (7)</h3></li><li><a href="http://www.medicinescomplete.com/mc/bnfc/2011/PHP13022-herpes-simplex-and-varicellazoster-infection.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">5.3.2.1 Herpes simplex and varicella–zoster infection</a><div class="breadcrumb"><p><strong>BNF for Children</strong> &gt; 5 Infections &gt; 5.3 Antiviral drugs &gt; 5.3.2 Herpesvirus infections</p></div></li><li><a href="http://www.medicinescomplete.com/mc/bnfc/2011/PHP13028-valaciclovir.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">VALACICLOVIR</a><div class="breadcrumb"><p><strong>BNF for Children</strong> &gt; 5 Infections &gt; 5.3 Antiviral drugs &gt; 5.3.2 Herpesvirus infections &gt; 5.3.2.1 Herpes simplex and varicella–zoster infection</p></div></li><li><a href="http://www.medicinescomplete.com/mc/bnfc/2011/PHP13029-valaciclovir-non-proprietary.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Valaciclovir</a><div class="breadcrumb"><p><strong>BNF for Children</strong> &gt; 5 Infections &gt; 5.3 Antiviral drugs &gt; 5.3.2 Herpesvirus infections &gt; 5.3.2.1 Herpes simplex and varicella–zoster infection &gt; VALACICLOVIR</p></div></li><li><a class="seeAll" href="http://www.medicinescomplete.com/mc/related.htm?q=%22valaciclovir%22%22valaciclovir%22" onclick="pageTracker._trackEvent('Related-Topic','Related-See-All');">see all (7)</a></li></ul><ul><li><h3>Clarke's Analysis of Drugs and Poisons</h3></li><li><a href="http://www.medicinescomplete.com/mc/clarke/2010/CLK1695.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Valaciclovir</a><div class="breadcrumb"><p><strong>Clarke's Analysis of Drugs and Poisons</strong> &gt; Monographs &gt; Alphabetically &gt; V</p></div></li></ul><ul><li><h3>Stability-Indicating HPLC Methods for Drug Analysis</h3></li><li><a href="http://www.medicinescomplete.com/mc/hplc/2008/ch0021s0001.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Valacyclovir Hydrochloride</a><div class="breadcrumb"><p><strong>Stability-Indicating HPLC Methods for Drug Analysis</strong> &gt; Monographs &gt; V</p></div></li></ul><ul><li><h3>Kucers' the Use of Antibiotics (7)</h3></li><li><a href="http://www.medicinescomplete.com/mc/kucers/2010/valaciclovir_description.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Description</a><div class="breadcrumb"><p><strong>Kucers' the Use of Antibiotics</strong> &gt; Anti-Viral Drugs &gt; Agents Active Against Herpesviruses &gt; 210 Valaciclovir</p></div></li><li><a href="http://www.medicinescomplete.com/mc/kucers/2010/valaciclovir_antimicrobial_activity.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Antimicrobial activity</a><div class="breadcrumb"><p><strong>Kucers' the Use of Antibiotics</strong> &gt; Anti-Viral Drugs &gt; Agents Active Against Herpesviruses &gt; 210 Valaciclovir</p></div></li><li><a href="http://www.medicinescomplete.com/mc/kucers/2010/valaciclovir_mechanism_of_drug_action.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Mechanism of drug action</a><div class="breadcrumb"><p><strong>Kucers' the Use of Antibiotics</strong> &gt; Anti-Viral Drugs &gt; Agents Active Against Herpesviruses &gt; 210 Valaciclovir</p></div></li><li><a class="seeAll" href="http://www.medicinescomplete.com/mc/related.htm?q=%22valaciclovir%22%22valaciclovir%22" onclick="pageTracker._trackEvent('Related-Topic','Related-See-All');">see all (7)</a></li></ul><ul><li><h3>Martindale: The Complete Drug Reference</h3></li><li><a href="http://www.medicinescomplete.com/mc/martindale/2009/17334-c.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Valaciclovir Hydrochloride</a><div class="breadcrumb"><p><strong>Martindale: The Complete Drug Reference</strong> &gt; Drugs and Ancillary Substances &gt; By therapeutic use &gt; Antivirals &gt; Drug Monographs</p></div></li></ul><ul><li><h3>The Merck Index</h3></li><li><a href="http://www.medicinescomplete.com/mc/merck/2010/09899.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Valacyclovir</a><div class="breadcrumb"><p><strong>The Merck Index</strong> &gt; Monographs &gt; V &gt; VA</p></div></li></ul><ul><li><h3>Remington: The Science and Practice of Pharmacy</h3></li><li><a href="http://www.medicinescomplete.com/mc/rem/2012/mono-V2.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Valacyclovir Hydrochloride</a><div class="breadcrumb"><p><strong>Remington: The Science and Practice of Pharmacy</strong> &gt; Part 3: Pharmaceutical and Medicinal Agents &gt; V</p></div></li></ul><ul><li><h3>Stockley's Drug Interactions</h3></li><li><a href="http://www.medicinescomplete.com/mc/stockley/2010/int-E2E0E4E3E0R0D1883.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Interactions of Valaciclovir</a><div class="breadcrumb"><p><strong>Stockley's Drug Interactions</strong> &gt; Interactants, Alphabetically &gt; V</p></div></li></ul><ul><li><h3>Drug Administration via Enteral Feeding Tubes</h3></li><li><a href="http://www.medicinescomplete.com/mc/tubes/2010/c377.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Valaciclovir</a><div class="breadcrumb"><p><strong>Drug Administration via Enteral Feeding Tubes</strong> &gt; Handbook of Drug Administration via Enteral Feeding Tubes &gt; Monographs &gt; V</p></div></li></ul><script type="text/javascript" src="scripts/sidebar.js"></script></div><div id="pB"><h1>VALACICLOVIR</h1><?highlighter on?><div id="pC" class="jN"><div class="cL"><div class="cE"><h3 class="cO">Additional information</h3> <p class="cT"> interactions (<a href="bnf_int394-valaciclovir.htm">Valaciclovir</a>).</p></div></div><div class="cG"><div class="cE"><h3 class="cT">Note</h3> <p class="cT">Valaciclovir is a pro-drug of aciclovir</p></div></div><div class="cL"><div class="cE"><h2 class="cN">Indications </h2> <p class="cT">treatment of herpes zoster; treatment of initial and suppression of recurrent herpes simplex infections of skin and mucous membranes including initial and recurrent genital herpes; reduction of transmission of genital herpes; prevention of cytomegalovirus disease following solid organ transplantation when valganciclovir or ganciclovir cannot be used</p></div> </div> <div class="cL"><div class="cE"><h2 class="cN">Cautions </h2> <p class="cT">see under <a title="target-text: Aciclovir cautions 1" href="PHP3843-aciclovir.htm#PHP3844">Aciclovir</a></p></div> </div> <div class="cL"><div class="cE"><h2 class="cN">Hepatic impairment </h2> <p class="cT">manufacturer advises caution with high doses used for herpes labialis and prevention of cytomegalovirus disease—no information available</p></div> </div> <div class="cL"><div class="cE"><h2 class="cN">Renal impairment </h2> <p class="cT">maintain adequate hydration; for <em>herpes zoster</em>, 1 g every 12 hours if eGFR 30–50 mL/minute/1.73 m<sup>2</sup> (1 g every 24 hours if eGFR 10–30 mL/minute/1.73 m<sup>2</sup>; 500 mg every 24 hours if eGFR less than 10 mL/minute/1.73 m<sup>2</sup>); for <em>treatment of herpes simplex</em>, 500 mg (1 g in immunocompromised or HIV-positive patients) every 24 hours if eGFR less than 30 mL/minute/1.73 m<sup>2</sup>; for <em>treatment of herpes labialis</em>, if eGFR 30–50 mL/minute/1.73 m<sup>2</sup>, initially 1 g, then 1 g 12 hours after initial dose (if eGFR 10–30 mL/minute/1.73 m<sup>2</sup>, initally 500 mg, then 500 mg 12 hours after initial dose; if eGFR less than 10 mL/minute/1.73 m<sup>2</sup>, 500 mg as a single dose); for <em>suppression of herpes simplex</em>, 250 mg (500 mg in immunocompromised or HIV-positive patients) every 24 hours if eGFR less than 30 mL/minute/1.73 m<sup>2</sup>; for <em>reduction of genital herpes transmission</em>, 250 mg every 24 hours if eGFR less than 15 mL/minute/1.73 m<sup>2</sup>; reduce dose according to eGFR for <em>cytomegalovirus prophylaxis</em> following solid organ transplantation (consult product literature)</p></div> </div> <div class="cL"><div class="cE"><h2 class="cN">Pregnancy </h2> <p class="cT">see under <a title="BNF:monograph: ACICLOVIR" href="PHP3843-aciclovir.htm">Aciclovir</a></p></div> </div> <div class="cL"><div class="cE"><h2 class="cN">Breast-feeding </h2> <p class="cT">see under <a title="BNF:monograph: ACICLOVIR" href="PHP3843-aciclovir.htm">Aciclovir</a></p></div> </div> <div class="cL"><div class="cE"><h2 class="cN">Side-effects </h2> <p class="cT">see under Aciclovir but neurological reactions more frequent with high doses</p></div> </div> <div class="cL"><h2 class="cM">Dose</h2><div class="cR"><ul><li><p>Herpes zoster, 1 g 3 times daily for 7 days (in immunocompromised continue for 2 days after crusting of lesions); <span class="cP">child</span> 12–18 years see <a title="BNFC:monograph: VALACICLOVIR" href="http://www.medicinescomplete.com/mc/bnfc/current/PHP13028.htm"><em>BNF for Children</em></a></p></li> <li><p>Herpes simplex, treatment of <em>first episode</em>, 500 mg twice daily for 5 days, longer if new lesions appear during treatment or if healing incomplete (1 g twice daily for 10 days in immunocompromised or HIV-positive patients); treatment of <em>recurrent infection</em>, 500 mg twice daily for 3–5 days (1 g twice daily for 5–10 days in immunocompromised or HIV-positive patients); <span class="cP">child</span> 12–18 years see <a title="BNFC:monograph: VALACICLOVIR" href="http://www.medicinescomplete.com/mc/bnfc/current/PHP13028.htm"><em>BNF for Children</em></a></p></li> <li><p>Herpes labialis, treatment, <span class="cP">adult</span> and <span class="cP">child</span> over 12 years, initially 2 g, then 2 g 12 hours after initial dose</p></li> <li><p>Herpes simplex, suppression, 500 mg daily in 1–2 divided doses (in immunocompromised or HIV positive patients, 500 mg twice daily); therapy interrupted every 6–12 months to reassess recurrence frequency—consider restarting after two or more recurrences; <span class="cP">child</span> 12–18 years see <a title="BNFC:monograph: VALACICLOVIR" href="http://www.medicinescomplete.com/mc/bnfc/current/PHP13028.htm"><em>BNF for Children</em></a></p></li> <li><p>Reduction of transmission of genital herpes, seek specialist advice, 500 mg once daily to be taken by the infected partner</p></li> <li><p>Prevention of cytomegalovirus disease following solid organ transplantation (preferably starting within 72 hours of transplantation), 2 g 4 times daily usually for 90 days; <span class="cP">child</span> 12–18 years see <a title="BNFC:monograph: VALACICLOVIR" href="http://www.medicinescomplete.com/mc/bnfc/current/PHP13028.htm"><em>BNF for Children</em></a></p></li> </ul></div></div> </div><div id="pS"><p>Sub-sections</p><ul class="jT"><li><a href="PHP3854-valaciclovir-non-proprietary.htm#PHP3854-valaciclovir-non-proprietary" title="Valaciclovir">Valaciclovir</a></li><li><a href="PHP3855-valtrex.htm#PHP3855-valtrex" title="Valtrex®">Valtrex®</a></li></ul></div><?highlighter off?><div id="pE">◄ <a accesskey="[" href="PHP3851-inosine-pranobex.htm">Previous: INOSINE PRANOBEX</a> | <a class="top" href="PHP3853-valaciclovir.htm#">Top</a> | <a accesskey="]" href="PHP3854-valaciclovir-non-proprietary.htm#PHP3854-valaciclovir-non-proprietary" title="Valaciclovir">Next: Valaciclovir</a> ►</div></div></div><div id="pF"><div id="pL"><div id="footer"><div id="footerinner"><ul><li><a accesskey="0" href="accessibility.htm" title="Accessibility information: access key 0">Accessibility</a> | </li><li><a href="http://www.medicinescomplete.com/mc/marketing/current/contact.htm">Contact Us</a> | </li><li><a href="privacy.htm" title="Cookie and Privacy Policy">Cookie and Privacy Policy</a> | </li><li><a accesskey="3" href="http://www.medicinescomplete.com/mc/sitemap.htm" title="Site Map: access key 3">Site Map</a> | </li><li><a accesskey="8" href="terms.htm" title="Terms and Conditions: access key 8">Terms and Conditions</a></li></ul></div></div></div><div id="pX"><p><a href="PHP0-publication-information.htm" rel="copyright">Copyright © BMJ Group and Pharmaceutical Press 2012. All rights reserved. </a></p></div></div><script type="text/javascript">$(document).ready(function(){$.ga('UA-9959526-1');});</script></body></html>